article thumbnail

The Hidden Costs of Initial Coin Offerings

Harvard Business Review

More recently, it has gained attention as a way to finance new ventures, through what is known as an Initial Coin Offering (ICO). Less noticed, though, is ICOs appear almost antithetical to the standard approach to financing a risky venture. Blockbuster capital raises will always occur in unusual situations (e.g.,

Cost 8
article thumbnail

An Insider’s Account of the Yahoo-Alibaba Deal

Harvard Business Review

content (news, finance, weather) into two Chinese languages, and directory access to 20,000 web sites, an approach that the company had adopted elsewhere. The company was owned by management, venture capitalists, and SoftBank. On the finance and deal side, we also felt a strong kinship with Tsai.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

‘My Years with General Motors’, Fifty Years On

Harvard Business Review

A central office kept track of finances and the allocation of resources. At General Motors, decision-rights were far more decentralized. GM was a behemoth, but its decentralized structure gave divisional leaders like Grant the freedom to direct strategy for their own product lines. Chandler (who researched Sloan’s book) put it.

article thumbnail

How Blockchain Is Changing Finance

Harvard Business Review

For example, consider how new business ventures access growth capital. Traditionally, companies target angel investors in the early stages of a new business, and later look to venture capitalists, eventually culminating in an initial public offering (IPO) on a stock exchange. ” Others are sure to follow suit.

article thumbnail

An Entrepreneurial Society Needs an Entrepreneurial State

Harvard Business Review

In Silicon Valley, what was critical was the decentralized network of intelligent public organizations that facilitated feedback loops throughout the whole innovation chain. This includes basic research, applied research, and downstream patient and strategic long-term finance to companies. billion in public support.